Home › Disfunction ng Kaliwang Ventrikulo › Texas
Pag-aaral pangklinika para sa Disfunction ng Kaliwang Ventrikulo sa Texas
4 pag-aaral para sa Disfunction ng Kaliwang Ventrikulo ang naghahanap ng mga kalahok sa mga site sa Texas.
Mga Lungsod sa Texas
Opisyal na teksto ng pag-aaral (English)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Children's Health-The Heart Center ( Site 0015), Dallas
- Texas Children's Hospital ( Site 0039), Houston
Nagre-recruitPhase 2/3
29 Days – 17 Years · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Medical Center Dallas - Cardiology, Dallas
- Texas Children's Hospital - Cardiology, Houston
Nagre-recruitPhase 3
Hanggang edad 18 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Medical Center Dallas - Cardiology, Dallas
- Texas Children's Hospital - Cardiology, Houston
Nagre-recruitPhase 3
6 Months – 17 Years · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT07188805AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Texas Cardiac Arrhythmia Research Foundation, Austin
- South Heart Clinic, Weslaco
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT06699056Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.